nodes	percent_of_prediction	percent_of_DWPC	metapath
Pyruvic acid—SLC16A8—retina—malignant glioma	0.0198	0.0406	CbGeAlD
Pyruvic acid—SLC16A8—medulla oblongata—malignant glioma	0.0143	0.0293	CbGeAlD
Pyruvic acid—SLC16A8—midbrain—malignant glioma	0.0131	0.0268	CbGeAlD
Pyruvic acid—PKM—embryo—malignant glioma	0.0113	0.0232	CbGeAlD
Pyruvic acid—PKLR—cerebellum—malignant glioma	0.0112	0.023	CbGeAlD
Pyruvic acid—SLC16A6—medulla oblongata—malignant glioma	0.0108	0.0222	CbGeAlD
Pyruvic acid—PDHB—retina—malignant glioma	0.0105	0.0215	CbGeAlD
Pyruvic acid—PC—embryo—malignant glioma	0.0104	0.0214	CbGeAlD
Pyruvic acid—PKM—brainstem—malignant glioma	0.0103	0.0212	CbGeAlD
Pyruvic acid—SLC16A8—cerebellum—malignant glioma	0.0101	0.0207	CbGeAlD
Pyruvic acid—PKM—retina—malignant glioma	0.00998	0.0205	CbGeAlD
Pyruvic acid—SLC16A4—medulla oblongata—malignant glioma	0.00998	0.0205	CbGeAlD
Pyruvic acid—SLC16A6—midbrain—malignant glioma	0.00991	0.0203	CbGeAlD
Pyruvic acid—SLC16A6—spinal cord—malignant glioma	0.00967	0.0198	CbGeAlD
Pyruvic acid—PDHB—telencephalon—malignant glioma	0.00962	0.0197	CbGeAlD
Pyruvic acid—PKM—telencephalon—malignant glioma	0.00918	0.0188	CbGeAlD
Pyruvic acid—SLC16A4—midbrain—malignant glioma	0.00912	0.0187	CbGeAlD
Pyruvic acid—SLC16A4—spinal cord—malignant glioma	0.0089	0.0183	CbGeAlD
Pyruvic acid—SLC16A8—brain—malignant glioma	0.00822	0.0169	CbGeAlD
Pyruvic acid—SLC16A6—cerebellum—malignant glioma	0.00767	0.0157	CbGeAlD
Pyruvic acid—SLC16A3—brainstem—malignant glioma	0.00765	0.0157	CbGeAlD
Pyruvic acid—PDHB—medulla oblongata—malignant glioma	0.00756	0.0155	CbGeAlD
Pyruvic acid—SLC16A3—retina—malignant glioma	0.00738	0.0151	CbGeAlD
Pyruvic acid—PKM—medulla oblongata—malignant glioma	0.00721	0.0148	CbGeAlD
Pyruvic acid—SLC16A4—cerebellum—malignant glioma	0.00706	0.0145	CbGeAlD
Pyruvic acid—ABAT—brainstem—malignant glioma	0.00695	0.0142	CbGeAlD
Pyruvic acid—PDHB—midbrain—malignant glioma	0.00691	0.0142	CbGeAlD
Pyruvic acid—SLC16A3—telencephalon—malignant glioma	0.00679	0.0139	CbGeAlD
Pyruvic acid—PDHB—spinal cord—malignant glioma	0.00674	0.0138	CbGeAlD
Pyruvic acid—ABAT—retina—malignant glioma	0.0067	0.0137	CbGeAlD
Pyruvic acid—PC—medulla oblongata—malignant glioma	0.00666	0.0137	CbGeAlD
Pyruvic acid—SLC16A7—telencephalon—malignant glioma	0.00648	0.0133	CbGeAlD
Pyruvic acid—PKM—spinal cord—malignant glioma	0.00643	0.0132	CbGeAlD
Pyruvic acid—SLC16A6—brain—malignant glioma	0.00623	0.0128	CbGeAlD
Pyruvic acid—ABAT—telencephalon—malignant glioma	0.00616	0.0126	CbGeAlD
Pyruvic acid—PC—midbrain—malignant glioma	0.00609	0.0125	CbGeAlD
Pyruvic acid—PC—spinal cord—malignant glioma	0.00594	0.0122	CbGeAlD
Pyruvic acid—SLC16A4—brain—malignant glioma	0.00573	0.0118	CbGeAlD
Pyruvic acid—PDHB—central nervous system—malignant glioma	0.00547	0.0112	CbGeAlD
Pyruvic acid—PDHB—cerebellum—malignant glioma	0.00535	0.011	CbGeAlD
Pyruvic acid—SLC16A3—medulla oblongata—malignant glioma	0.00534	0.0109	CbGeAlD
Pyruvic acid—PKM—central nervous system—malignant glioma	0.00522	0.0107	CbGeAlD
Pyruvic acid—PKM—cerebellum—malignant glioma	0.0051	0.0105	CbGeAlD
Pyruvic acid—SLC16A7—medulla oblongata—malignant glioma	0.00509	0.0104	CbGeAlD
Pyruvic acid—SLC16A2—medulla oblongata—malignant glioma	0.00487	0.01	CbGeAlD
Pyruvic acid—ABAT—medulla oblongata—malignant glioma	0.00484	0.00993	CbGeAlD
Pyruvic acid—PC—central nervous system—malignant glioma	0.00482	0.00988	CbGeAlD
Pyruvic acid—PC—cerebellum—malignant glioma	0.00471	0.00966	CbGeAlD
Pyruvic acid—SLC16A7—midbrain—malignant glioma	0.00465	0.00955	CbGeAlD
Pyruvic acid—SLC16A1—retina—malignant glioma	0.00448	0.0092	CbGeAlD
Pyruvic acid—ABAT—midbrain—malignant glioma	0.00443	0.00908	CbGeAlD
Pyruvic acid—SLC16A2—spinal cord—malignant glioma	0.00435	0.00891	CbGeAlD
Pyruvic acid—PDHB—brain—malignant glioma	0.00434	0.00891	CbGeAlD
Pyruvic acid—ABAT—spinal cord—malignant glioma	0.00432	0.00886	CbGeAlD
Pyruvic acid—PKM—brain—malignant glioma	0.00414	0.0085	CbGeAlD
Pyruvic acid—SLC16A1—telencephalon—malignant glioma	0.00413	0.00846	CbGeAlD
Pyruvic acid—SLC16A3—central nervous system—malignant glioma	0.00386	0.00792	CbGeAlD
Pyruvic acid—PC—brain—malignant glioma	0.00382	0.00784	CbGeAlD
Pyruvic acid—SLC16A3—cerebellum—malignant glioma	0.00377	0.00774	CbGeAlD
Pyruvic acid—SLC16A7—central nervous system—malignant glioma	0.00368	0.00756	CbGeAlD
Pyruvic acid—SLC16A7—cerebellum—malignant glioma	0.0036	0.00739	CbGeAlD
Pyruvic acid—SLC16A2—central nervous system—malignant glioma	0.00353	0.00723	CbGeAlD
Pyruvic acid—ABAT—central nervous system—malignant glioma	0.0035	0.00719	CbGeAlD
Pyruvic acid—SLC16A2—cerebellum—malignant glioma	0.00345	0.00707	CbGeAlD
Pyruvic acid—ABAT—cerebellum—malignant glioma	0.00342	0.00702	CbGeAlD
Pyruvic acid—SLC16A1—medulla oblongata—malignant glioma	0.00324	0.00665	CbGeAlD
Pyruvic acid—SLC16A3—brain—malignant glioma	0.00306	0.00629	CbGeAlD
Pyruvic acid—SLC16A1—midbrain—malignant glioma	0.00296	0.00608	CbGeAlD
Pyruvic acid—SLC16A7—brain—malignant glioma	0.00292	0.006	CbGeAlD
Pyruvic acid—SLC16A1—spinal cord—malignant glioma	0.00289	0.00593	CbGeAlD
Pyruvic acid—SLCO2A1—central nervous system—malignant glioma	0.00282	0.00578	CbGeAlD
Pyruvic acid—SLC16A2—brain—malignant glioma	0.0028	0.00574	CbGeAlD
Pyruvic acid—ABAT—brain—malignant glioma	0.00278	0.00571	CbGeAlD
Pyruvic acid—SLC16A1—central nervous system—malignant glioma	0.00234	0.00481	CbGeAlD
Pyruvic acid—SLC16A1—cerebellum—malignant glioma	0.00229	0.0047	CbGeAlD
Pyruvic acid—SLCO2A1—brain—malignant glioma	0.00224	0.00459	CbGeAlD
Pyruvic acid—SLC16A10—cerebellum—malignant glioma	0.00222	0.00456	CbGeAlD
Pyruvic acid—SLC16A1—brain—malignant glioma	0.00186	0.00382	CbGeAlD
Pyruvic acid—PKLR—Disease—NCOR1—malignant glioma	0.0003	0.000585	CbGpPWpGaD
Pyruvic acid—SLC16A3—Hemostasis—PIK3CG—malignant glioma	0.000296	0.000578	CbGpPWpGaD
Pyruvic acid—SLC16A3—Hemostasis—EGF—malignant glioma	0.000293	0.000572	CbGpPWpGaD
Pyruvic acid—AGXT2—Metabolism—BCHE—malignant glioma	0.000292	0.00057	CbGpPWpGaD
Pyruvic acid—SLC16A3—Hemostasis—PTPN11—malignant glioma	0.000291	0.000568	CbGpPWpGaD
Pyruvic acid—PC—Metabolism—PTGS1—malignant glioma	0.00029	0.000566	CbGpPWpGaD
Pyruvic acid—AGXT2—Metabolism—SLC5A5—malignant glioma	0.000289	0.000563	CbGpPWpGaD
Pyruvic acid—PKLR—Disease—PDGFRA—malignant glioma	0.000287	0.00056	CbGpPWpGaD
Pyruvic acid—PKM—Disease—BAD—malignant glioma	0.000285	0.000557	CbGpPWpGaD
Pyruvic acid—SLC16A10—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000284	0.000554	CbGpPWpGaD
Pyruvic acid—PKM—Disease—NOTCH1—malignant glioma	0.000283	0.000551	CbGpPWpGaD
Pyruvic acid—PKLR—Developmental Biology—VEGFA—malignant glioma	0.00028	0.000547	CbGpPWpGaD
Pyruvic acid—PKLR—Developmental Biology—STAT3—malignant glioma	0.000278	0.000542	CbGpPWpGaD
Pyruvic acid—PKM—Disease—CD80—malignant glioma	0.000277	0.00054	CbGpPWpGaD
Pyruvic acid—PKM—Disease—APC—malignant glioma	0.000276	0.000539	CbGpPWpGaD
Pyruvic acid—SLC16A1—Cell surface interactions at the vascular wall—PIK3CA—malignant glioma	0.000276	0.000538	CbGpPWpGaD
Pyruvic acid—SLC16A8—Hemostasis—VEGFA—malignant glioma	0.000275	0.000537	CbGpPWpGaD
Pyruvic acid—SLC16A1—Metabolism—ASMT—malignant glioma	0.000275	0.000536	CbGpPWpGaD
Pyruvic acid—SLC16A1—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000275	0.000536	CbGpPWpGaD
Pyruvic acid—PKLR—Metabolism—GSTP1—malignant glioma	0.000273	0.000533	CbGpPWpGaD
Pyruvic acid—SLC16A8—Metabolism—GSTP1—malignant glioma	0.000273	0.000533	CbGpPWpGaD
Pyruvic acid—PKM—Disease—EGF—malignant glioma	0.000273	0.000533	CbGpPWpGaD
Pyruvic acid—PKM—Disease—PTPN11—malignant glioma	0.000271	0.00053	CbGpPWpGaD
Pyruvic acid—SLC16A3—Hemostasis—AKT2—malignant glioma	0.000271	0.000529	CbGpPWpGaD
Pyruvic acid—PDHB—Metabolism—CAV1—malignant glioma	0.00027	0.000527	CbGpPWpGaD
Pyruvic acid—SLC16A10—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.00027	0.000527	CbGpPWpGaD
Pyruvic acid—PC—Metabolism—BCHE—malignant glioma	0.00027	0.000526	CbGpPWpGaD
Pyruvic acid—PC—Metabolism—SLC5A5—malignant glioma	0.000266	0.00052	CbGpPWpGaD
Pyruvic acid—SLC16A8—Metabolism—CAT—malignant glioma	0.000266	0.000519	CbGpPWpGaD
Pyruvic acid—PKLR—Metabolism—CAT—malignant glioma	0.000266	0.000519	CbGpPWpGaD
Pyruvic acid—PKLR—Disease—TERT—malignant glioma	0.000264	0.000516	CbGpPWpGaD
Pyruvic acid—PKLR—Disease—HLA-A—malignant glioma	0.000264	0.000516	CbGpPWpGaD
Pyruvic acid—SLC16A3—Hemostasis—PIK3CD—malignant glioma	0.000261	0.000508	CbGpPWpGaD
Pyruvic acid—PKM—Disease—BRAF—malignant glioma	0.00026	0.000507	CbGpPWpGaD
Pyruvic acid—SLC16A1—Hemostasis—KNG1—malignant glioma	0.000259	0.000505	CbGpPWpGaD
Pyruvic acid—SLC16A1—Metabolism—BCAN—malignant glioma	0.000258	0.000504	CbGpPWpGaD
Pyruvic acid—PKLR—Disease—PDGFB—malignant glioma	0.000258	0.000503	CbGpPWpGaD
Pyruvic acid—PKLR—Disease—FGFR1—malignant glioma	0.000257	0.000501	CbGpPWpGaD
Pyruvic acid—SLC16A7—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000255	0.000497	CbGpPWpGaD
Pyruvic acid—SLC16A3—Metabolism—GSTT1—malignant glioma	0.000254	0.000496	CbGpPWpGaD
Pyruvic acid—PKM—Metabolism—CAV1—malignant glioma	0.000254	0.000496	CbGpPWpGaD
Pyruvic acid—SLC16A1—Hemostasis—IFNA2—malignant glioma	0.000254	0.000495	CbGpPWpGaD
Pyruvic acid—PKM—Disease—AKT2—malignant glioma	0.000253	0.000493	CbGpPWpGaD
Pyruvic acid—PKLR—Disease—HIF1A—malignant glioma	0.000253	0.000493	CbGpPWpGaD
Pyruvic acid—PKLR—Developmental Biology—EGFR—malignant glioma	0.000252	0.000492	CbGpPWpGaD
Pyruvic acid—SLC16A1—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000252	0.000492	CbGpPWpGaD
Pyruvic acid—PKLR—Metabolism—NCOR1—malignant glioma	0.000251	0.00049	CbGpPWpGaD
Pyruvic acid—SLC16A8—Metabolism—NCOR1—malignant glioma	0.000251	0.00049	CbGpPWpGaD
Pyruvic acid—PC—Disease—CDKN2B—malignant glioma	0.000248	0.000484	CbGpPWpGaD
Pyruvic acid—PDHB—Metabolism—PIK3CG—malignant glioma	0.000246	0.00048	CbGpPWpGaD
Pyruvic acid—PKLR—Disease—CAV1—malignant glioma	0.000244	0.000477	CbGpPWpGaD
Pyruvic acid—PKM—Disease—PIK3CD—malignant glioma	0.000243	0.000474	CbGpPWpGaD
Pyruvic acid—PKLR—Developmental Biology—TNF—malignant glioma	0.00024	0.000469	CbGpPWpGaD
Pyruvic acid—SLC16A1—Hemostasis—SOD1—malignant glioma	0.00024	0.000469	CbGpPWpGaD
Pyruvic acid—SLC16A1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.00024	0.000468	CbGpPWpGaD
Pyruvic acid—PKLR—Developmental Biology—KRAS—malignant glioma	0.000238	0.000465	CbGpPWpGaD
Pyruvic acid—SLC16A3—Metabolism—PTGS1—malignant glioma	0.000238	0.000465	CbGpPWpGaD
Pyruvic acid—PDHB—Metabolism—PPARG—malignant glioma	0.000238	0.000463	CbGpPWpGaD
Pyruvic acid—PC—Disease—HES1—malignant glioma	0.000237	0.000462	CbGpPWpGaD
Pyruvic acid—PC—Disease—NCOR1—malignant glioma	0.000235	0.000459	CbGpPWpGaD
Pyruvic acid—SLC16A8—Hemostasis—KRAS—malignant glioma	0.000234	0.000456	CbGpPWpGaD
Pyruvic acid—SLC16A3—Hemostasis—RAF1—malignant glioma	0.000233	0.000454	CbGpPWpGaD
Pyruvic acid—PKM—Disease—FGF2—malignant glioma	0.000233	0.000454	CbGpPWpGaD
Pyruvic acid—AGXT2—Metabolism—GSTP1—malignant glioma	0.000232	0.000453	CbGpPWpGaD
Pyruvic acid—PKM—Metabolism—PIK3CG—malignant glioma	0.000231	0.000451	CbGpPWpGaD
Pyruvic acid—PKLR—Disease—BAD—malignant glioma	0.00023	0.000449	CbGpPWpGaD
Pyruvic acid—PKLR—Disease—NOTCH1—malignant glioma	0.000228	0.000444	CbGpPWpGaD
Pyruvic acid—SLC16A3—Hemostasis—PIK3CB—malignant glioma	0.000227	0.000443	CbGpPWpGaD
Pyruvic acid—AGXT2—Metabolism—CAT—malignant glioma	0.000226	0.000441	CbGpPWpGaD
Pyruvic acid—PC—Disease—PDGFRA—malignant glioma	0.000225	0.00044	CbGpPWpGaD
Pyruvic acid—PKM—Metabolism—PPARG—malignant glioma	0.000223	0.000436	CbGpPWpGaD
Pyruvic acid—PKLR—Disease—CD80—malignant glioma	0.000223	0.000435	CbGpPWpGaD
Pyruvic acid—PKLR—Disease—APC—malignant glioma	0.000223	0.000435	CbGpPWpGaD
Pyruvic acid—SLCO2A1—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000223	0.000435	CbGpPWpGaD
Pyruvic acid—SLC16A3—Metabolism—BCHE—malignant glioma	0.000221	0.000432	CbGpPWpGaD
Pyruvic acid—SLC16A1—Hemostasis—PTK2—malignant glioma	0.000221	0.000431	CbGpPWpGaD
Pyruvic acid—PKLR—Disease—EGF—malignant glioma	0.00022	0.00043	CbGpPWpGaD
Pyruvic acid—PKLR—Disease—PTPN11—malignant glioma	0.000219	0.000427	CbGpPWpGaD
Pyruvic acid—SLC16A3—Metabolism—SLC5A5—malignant glioma	0.000219	0.000427	CbGpPWpGaD
Pyruvic acid—PKM—Disease—MDM2—malignant glioma	0.000218	0.000425	CbGpPWpGaD
Pyruvic acid—PKM—Disease—RAF1—malignant glioma	0.000217	0.000423	CbGpPWpGaD
Pyruvic acid—PDHB—Metabolism—PIK3CD—malignant glioma	0.000216	0.000422	CbGpPWpGaD
Pyruvic acid—SLC16A8—Hemostasis—PIK3CA—malignant glioma	0.000215	0.000419	CbGpPWpGaD
Pyruvic acid—PKM—Disease—ERBB2—malignant glioma	0.000215	0.000419	CbGpPWpGaD
Pyruvic acid—PC—Metabolism—GSTP1—malignant glioma	0.000214	0.000419	CbGpPWpGaD
Pyruvic acid—AGXT2—Metabolism—NCOR1—malignant glioma	0.000214	0.000417	CbGpPWpGaD
Pyruvic acid—PKM—Disease—PIK3CB—malignant glioma	0.000212	0.000413	CbGpPWpGaD
Pyruvic acid—PKM—Disease—PTGS2—malignant glioma	0.00021	0.000409	CbGpPWpGaD
Pyruvic acid—PKLR—Disease—BRAF—malignant glioma	0.000209	0.000408	CbGpPWpGaD
Pyruvic acid—PC—Metabolism—CAT—malignant glioma	0.000209	0.000407	CbGpPWpGaD
Pyruvic acid—SLC16A3—Hemostasis—IL2—malignant glioma	0.000209	0.000407	CbGpPWpGaD
Pyruvic acid—SLC16A1—Metabolism—IDH2—malignant glioma	0.000208	0.000406	CbGpPWpGaD
Pyruvic acid—SLC16A8—Hemostasis—TP53—malignant glioma	0.000208	0.000406	CbGpPWpGaD
Pyruvic acid—PC—Disease—TERT—malignant glioma	0.000207	0.000405	CbGpPWpGaD
Pyruvic acid—PC—Disease—HLA-A—malignant glioma	0.000207	0.000405	CbGpPWpGaD
Pyruvic acid—PKLR—Metabolism—CAV1—malignant glioma	0.000205	0.0004	CbGpPWpGaD
Pyruvic acid—SLC16A8—Metabolism—CAV1—malignant glioma	0.000205	0.0004	CbGpPWpGaD
Pyruvic acid—PKLR—Disease—AKT2—malignant glioma	0.000204	0.000398	CbGpPWpGaD
Pyruvic acid—PKM—Metabolism—PIK3CD—malignant glioma	0.000203	0.000397	CbGpPWpGaD
Pyruvic acid—PC—Disease—PDGFB—malignant glioma	0.000202	0.000395	CbGpPWpGaD
Pyruvic acid—PC—Disease—FGFR1—malignant glioma	0.000201	0.000393	CbGpPWpGaD
Pyruvic acid—SLC16A3—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000201	0.000393	CbGpPWpGaD
Pyruvic acid—PC—Disease—HIF1A—malignant glioma	0.000198	0.000387	CbGpPWpGaD
Pyruvic acid—PC—Metabolism—NCOR1—malignant glioma	0.000197	0.000385	CbGpPWpGaD
Pyruvic acid—PKLR—Disease—PIK3CD—malignant glioma	0.000196	0.000382	CbGpPWpGaD
Pyruvic acid—SLC16A1—Metabolism—CYP2B6—malignant glioma	0.000196	0.000382	CbGpPWpGaD
Pyruvic acid—PC—Disease—CAV1—malignant glioma	0.000192	0.000374	CbGpPWpGaD
Pyruvic acid—PDHB—Metabolism—PIK3CB—malignant glioma	0.000189	0.000368	CbGpPWpGaD
Pyruvic acid—PKLR—Disease—FGF2—malignant glioma	0.000187	0.000366	CbGpPWpGaD
Pyruvic acid—PDHB—Metabolism—PTGS2—malignant glioma	0.000187	0.000365	CbGpPWpGaD
Pyruvic acid—SLC16A8—Metabolism—PIK3CG—malignant glioma	0.000187	0.000364	CbGpPWpGaD
Pyruvic acid—PKLR—Metabolism—PIK3CG—malignant glioma	0.000187	0.000364	CbGpPWpGaD
Pyruvic acid—SLC16A1—Hemostasis—PDGFB—malignant glioma	0.000185	0.000362	CbGpPWpGaD
Pyruvic acid—PKM—Disease—PTEN—malignant glioma	0.000183	0.000357	CbGpPWpGaD
Pyruvic acid—PC—Disease—BAD—malignant glioma	0.00018	0.000352	CbGpPWpGaD
Pyruvic acid—PKLR—Metabolism—PPARG—malignant glioma	0.00018	0.000351	CbGpPWpGaD
Pyruvic acid—SLC16A8—Metabolism—PPARG—malignant glioma	0.00018	0.000351	CbGpPWpGaD
Pyruvic acid—SLC16A1—Metabolism—IDH1—malignant glioma	0.000179	0.000349	CbGpPWpGaD
Pyruvic acid—PKLR—Developmental Biology—AKT1—malignant glioma	0.000179	0.000349	CbGpPWpGaD
Pyruvic acid—PC—Disease—NOTCH1—malignant glioma	0.000179	0.000349	CbGpPWpGaD
Pyruvic acid—PKM—Metabolism—PIK3CB—malignant glioma	0.000177	0.000346	CbGpPWpGaD
Pyruvic acid—SLC16A3—Hemostasis—VEGFA—malignant glioma	0.000177	0.000346	CbGpPWpGaD
Pyruvic acid—SLC16A3—Metabolism—GSTP1—malignant glioma	0.000176	0.000344	CbGpPWpGaD
Pyruvic acid—SLC16A1—Hemostasis—CAV1—malignant glioma	0.000176	0.000343	CbGpPWpGaD
Pyruvic acid—PKM—Metabolism—PTGS2—malignant glioma	0.000176	0.000343	CbGpPWpGaD
Pyruvic acid—SLC16A8—Hemostasis—AKT1—malignant glioma	0.000176	0.000343	CbGpPWpGaD
Pyruvic acid—PKLR—Disease—MDM2—malignant glioma	0.000175	0.000342	CbGpPWpGaD
Pyruvic acid—PC—Disease—CD80—malignant glioma	0.000175	0.000342	CbGpPWpGaD
Pyruvic acid—PKLR—Disease—RAF1—malignant glioma	0.000175	0.000341	CbGpPWpGaD
Pyruvic acid—PC—Disease—APC—malignant glioma	0.000175	0.000341	CbGpPWpGaD
Pyruvic acid—AGXT2—Metabolism—CAV1—malignant glioma	0.000174	0.00034	CbGpPWpGaD
Pyruvic acid—SLC16A1—Metabolism—SPHK1—malignant glioma	0.000173	0.000338	CbGpPWpGaD
Pyruvic acid—PKLR—Disease—ERBB2—malignant glioma	0.000173	0.000337	CbGpPWpGaD
Pyruvic acid—PC—Disease—EGF—malignant glioma	0.000173	0.000337	CbGpPWpGaD
Pyruvic acid—PC—Disease—PTPN11—malignant glioma	0.000172	0.000335	CbGpPWpGaD
Pyruvic acid—SLC16A3—Metabolism—CAT—malignant glioma	0.000171	0.000334	CbGpPWpGaD
Pyruvic acid—PKLR—Disease—PIK3CB—malignant glioma	0.000171	0.000333	CbGpPWpGaD
Pyruvic acid—SLC16A1—Metabolism—CYP2C18—malignant glioma	0.00017	0.000331	CbGpPWpGaD
Pyruvic acid—PKLR—Disease—PTGS2—malignant glioma	0.000169	0.00033	CbGpPWpGaD
Pyruvic acid—SLC16A1—Hemostasis—FN1—malignant glioma	0.000167	0.000326	CbGpPWpGaD
Pyruvic acid—SLC16A1—Hemostasis—F2—malignant glioma	0.000167	0.000326	CbGpPWpGaD
Pyruvic acid—PC—Disease—BRAF—malignant glioma	0.000164	0.000321	CbGpPWpGaD
Pyruvic acid—PKLR—Metabolism—PIK3CD—malignant glioma	0.000164	0.00032	CbGpPWpGaD
Pyruvic acid—SLC16A8—Metabolism—PIK3CD—malignant glioma	0.000164	0.00032	CbGpPWpGaD
Pyruvic acid—PKM—Disease—STAT3—malignant glioma	0.000164	0.000319	CbGpPWpGaD
Pyruvic acid—PDHB—Metabolism—PTEN—malignant glioma	0.000163	0.000318	CbGpPWpGaD
Pyruvic acid—SLC16A3—Metabolism—NCOR1—malignant glioma	0.000162	0.000316	CbGpPWpGaD
Pyruvic acid—PC—Metabolism—CAV1—malignant glioma	0.000161	0.000314	CbGpPWpGaD
Pyruvic acid—SLC16A1—Hemostasis—PIK3CG—malignant glioma	0.00016	0.000312	CbGpPWpGaD
Pyruvic acid—PC—Disease—AKT2—malignant glioma	0.00016	0.000312	CbGpPWpGaD
Pyruvic acid—AGXT2—Metabolism—PIK3CG—malignant glioma	0.000159	0.000309	CbGpPWpGaD
Pyruvic acid—SLC16A1—Hemostasis—EGF—malignant glioma	0.000158	0.000309	CbGpPWpGaD
Pyruvic acid—SLC16A1—Hemostasis—PTPN11—malignant glioma	0.000157	0.000307	CbGpPWpGaD
Pyruvic acid—PC—Disease—PIK3CD—malignant glioma	0.000154	0.0003	CbGpPWpGaD
Pyruvic acid—PKM—Metabolism—PTEN—malignant glioma	0.000153	0.000299	CbGpPWpGaD
Pyruvic acid—AGXT2—Metabolism—PPARG—malignant glioma	0.000153	0.000299	CbGpPWpGaD
Pyruvic acid—PKM—Disease—MYC—malignant glioma	0.000152	0.000297	CbGpPWpGaD
Pyruvic acid—SLC16A3—Hemostasis—KRAS—malignant glioma	0.000151	0.000294	CbGpPWpGaD
Pyruvic acid—PKM—Disease—EGFR—malignant glioma	0.000149	0.00029	CbGpPWpGaD
Pyruvic acid—PKLR—Disease—PTEN—malignant glioma	0.000147	0.000288	CbGpPWpGaD
Pyruvic acid—PC—Disease—FGF2—malignant glioma	0.000147	0.000287	CbGpPWpGaD
Pyruvic acid—SLC16A1—Hemostasis—AKT2—malignant glioma	0.000146	0.000286	CbGpPWpGaD
Pyruvic acid—PC—Metabolism—PIK3CG—malignant glioma	0.000146	0.000286	CbGpPWpGaD
Pyruvic acid—SLC16A8—Metabolism—PIK3CB—malignant glioma	0.000143	0.000279	CbGpPWpGaD
Pyruvic acid—PKLR—Metabolism—PIK3CB—malignant glioma	0.000143	0.000279	CbGpPWpGaD
Pyruvic acid—PKLR—Metabolism—PTGS2—malignant glioma	0.000142	0.000276	CbGpPWpGaD
Pyruvic acid—SLC16A8—Metabolism—PTGS2—malignant glioma	0.000142	0.000276	CbGpPWpGaD
Pyruvic acid—PC—Metabolism—PPARG—malignant glioma	0.000141	0.000276	CbGpPWpGaD
Pyruvic acid—SLC16A1—Hemostasis—PIK3CD—malignant glioma	0.000141	0.000275	CbGpPWpGaD
Pyruvic acid—PKM—Disease—KRAS—malignant glioma	0.00014	0.000274	CbGpPWpGaD
Pyruvic acid—AGXT2—Metabolism—PIK3CD—malignant glioma	0.000139	0.000272	CbGpPWpGaD
Pyruvic acid—SLC16A3—Hemostasis—PIK3CA—malignant glioma	0.000138	0.00027	CbGpPWpGaD
Pyruvic acid—PC—Disease—MDM2—malignant glioma	0.000138	0.000269	CbGpPWpGaD
Pyruvic acid—SLC16A1—Metabolism—GSTT1—malignant glioma	0.000137	0.000268	CbGpPWpGaD
Pyruvic acid—PC—Disease—RAF1—malignant glioma	0.000137	0.000268	CbGpPWpGaD
Pyruvic acid—PC—Disease—ERBB2—malignant glioma	0.000136	0.000265	CbGpPWpGaD
Pyruvic acid—SLC16A3—Hemostasis—TP53—malignant glioma	0.000134	0.000261	CbGpPWpGaD
Pyruvic acid—PC—Disease—PIK3CB—malignant glioma	0.000134	0.000261	CbGpPWpGaD
Pyruvic acid—PC—Disease—PTGS2—malignant glioma	0.000133	0.000259	CbGpPWpGaD
Pyruvic acid—SLC16A3—Metabolism—CAV1—malignant glioma	0.000132	0.000257	CbGpPWpGaD
Pyruvic acid—PKLR—Disease—STAT3—malignant glioma	0.000132	0.000257	CbGpPWpGaD
Pyruvic acid—PKM—Disease—PIK3CA—malignant glioma	0.000129	0.000252	CbGpPWpGaD
Pyruvic acid—PC—Metabolism—PIK3CD—malignant glioma	0.000129	0.000251	CbGpPWpGaD
Pyruvic acid—SLC16A1—Metabolism—PTGS1—malignant glioma	0.000129	0.000251	CbGpPWpGaD
Pyruvic acid—SLC16A1—Hemostasis—RAF1—malignant glioma	0.000126	0.000245	CbGpPWpGaD
Pyruvic acid—SLC16A8—Metabolism—PTEN—malignant glioma	0.000123	0.000241	CbGpPWpGaD
Pyruvic acid—PKLR—Metabolism—PTEN—malignant glioma	0.000123	0.000241	CbGpPWpGaD
Pyruvic acid—SLC16A1—Hemostasis—PIK3CB—malignant glioma	0.000123	0.000239	CbGpPWpGaD
Pyruvic acid—PKLR—Disease—MYC—malignant glioma	0.000123	0.000239	CbGpPWpGaD
Pyruvic acid—SLC16A10—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000122	0.000239	CbGpPWpGaD
Pyruvic acid—AGXT2—Metabolism—PIK3CB—malignant glioma	0.000122	0.000237	CbGpPWpGaD
Pyruvic acid—AGXT2—Metabolism—PTGS2—malignant glioma	0.00012	0.000235	CbGpPWpGaD
Pyruvic acid—SLC16A3—Metabolism—PIK3CG—malignant glioma	0.00012	0.000235	CbGpPWpGaD
Pyruvic acid—PKLR—Disease—EGFR—malignant glioma	0.00012	0.000234	CbGpPWpGaD
Pyruvic acid—SLC16A1—Metabolism—BCHE—malignant glioma	0.00012	0.000233	CbGpPWpGaD
Pyruvic acid—SLC16A1—Metabolism—SLC5A5—malignant glioma	0.000118	0.00023	CbGpPWpGaD
Pyruvic acid—SLC16A3—Metabolism—PPARG—malignant glioma	0.000116	0.000226	CbGpPWpGaD
Pyruvic acid—PC—Disease—PTEN—malignant glioma	0.000116	0.000226	CbGpPWpGaD
Pyruvic acid—PDHB—Metabolism—PIK3CA—malignant glioma	0.000115	0.000224	CbGpPWpGaD
Pyruvic acid—PKLR—Disease—KRAS—malignant glioma	0.000113	0.000221	CbGpPWpGaD
Pyruvic acid—SLC16A3—Hemostasis—AKT1—malignant glioma	0.000113	0.000221	CbGpPWpGaD
Pyruvic acid—SLC16A1—Hemostasis—IL2—malignant glioma	0.000113	0.00022	CbGpPWpGaD
Pyruvic acid—PC—Metabolism—PIK3CB—malignant glioma	0.000112	0.000219	CbGpPWpGaD
Pyruvic acid—PC—Metabolism—PTGS2—malignant glioma	0.000111	0.000217	CbGpPWpGaD
Pyruvic acid—SLC16A1—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000109	0.000212	CbGpPWpGaD
Pyruvic acid—PKM—Metabolism—PIK3CA—malignant glioma	0.000108	0.000211	CbGpPWpGaD
Pyruvic acid—SLC16A3—Metabolism—PIK3CD—malignant glioma	0.000106	0.000206	CbGpPWpGaD
Pyruvic acid—PKM—Disease—AKT1—malignant glioma	0.000105	0.000206	CbGpPWpGaD
Pyruvic acid—AGXT2—Metabolism—PTEN—malignant glioma	0.000105	0.000205	CbGpPWpGaD
Pyruvic acid—PKLR—Disease—PIK3CA—malignant glioma	0.000104	0.000203	CbGpPWpGaD
Pyruvic acid—PC—Disease—STAT3—malignant glioma	0.000103	0.000202	CbGpPWpGaD
Pyruvic acid—PC—Metabolism—PTEN—malignant glioma	9.69e-05	0.000189	CbGpPWpGaD
Pyruvic acid—PC—Disease—MYC—malignant glioma	9.62e-05	0.000188	CbGpPWpGaD
Pyruvic acid—SLC16A1—Hemostasis—VEGFA—malignant glioma	9.57e-05	0.000187	CbGpPWpGaD
Pyruvic acid—SLC16A1—Metabolism—GSTP1—malignant glioma	9.51e-05	0.000186	CbGpPWpGaD
Pyruvic acid—PC—Disease—EGFR—malignant glioma	9.41e-05	0.000184	CbGpPWpGaD
Pyruvic acid—PDHB—Metabolism—AKT1—malignant glioma	9.39e-05	0.000183	CbGpPWpGaD
Pyruvic acid—SLC16A1—Metabolism—CAT—malignant glioma	9.26e-05	0.000181	CbGpPWpGaD
Pyruvic acid—SLC16A3—Metabolism—PIK3CB—malignant glioma	9.21e-05	0.00018	CbGpPWpGaD
Pyruvic acid—SLC16A3—Metabolism—PTGS2—malignant glioma	9.12e-05	0.000178	CbGpPWpGaD
Pyruvic acid—PC—Disease—KRAS—malignant glioma	8.88e-05	0.000173	CbGpPWpGaD
Pyruvic acid—PKM—Metabolism—AKT1—malignant glioma	8.83e-05	0.000172	CbGpPWpGaD
Pyruvic acid—SLC16A1—Metabolism—NCOR1—malignant glioma	8.74e-05	0.000171	CbGpPWpGaD
Pyruvic acid—PKLR—Metabolism—PIK3CA—malignant glioma	8.71e-05	0.00017	CbGpPWpGaD
Pyruvic acid—SLC16A8—Metabolism—PIK3CA—malignant glioma	8.71e-05	0.00017	CbGpPWpGaD
Pyruvic acid—PKLR—Disease—AKT1—malignant glioma	8.5e-05	0.000166	CbGpPWpGaD
Pyruvic acid—PC—Disease—PIK3CA—malignant glioma	8.16e-05	0.000159	CbGpPWpGaD
Pyruvic acid—SLC16A1—Hemostasis—KRAS—malignant glioma	8.14e-05	0.000159	CbGpPWpGaD
Pyruvic acid—SLC16A3—Metabolism—PTEN—malignant glioma	7.96e-05	0.000155	CbGpPWpGaD
Pyruvic acid—SLC16A1—Hemostasis—PIK3CA—malignant glioma	7.48e-05	0.000146	CbGpPWpGaD
Pyruvic acid—AGXT2—Metabolism—PIK3CA—malignant glioma	7.41e-05	0.000145	CbGpPWpGaD
Pyruvic acid—SLC16A1—Hemostasis—TP53—malignant glioma	7.23e-05	0.000141	CbGpPWpGaD
Pyruvic acid—SLC16A1—Metabolism—CAV1—malignant glioma	7.12e-05	0.000139	CbGpPWpGaD
Pyruvic acid—SLC16A8—Metabolism—AKT1—malignant glioma	7.12e-05	0.000139	CbGpPWpGaD
Pyruvic acid—PKLR—Metabolism—AKT1—malignant glioma	7.12e-05	0.000139	CbGpPWpGaD
Pyruvic acid—PC—Metabolism—PIK3CA—malignant glioma	6.84e-05	0.000133	CbGpPWpGaD
Pyruvic acid—PC—Disease—AKT1—malignant glioma	6.67e-05	0.00013	CbGpPWpGaD
Pyruvic acid—SLC16A1—Metabolism—PIK3CG—malignant glioma	6.49e-05	0.000127	CbGpPWpGaD
Pyruvic acid—SLC16A1—Metabolism—PPARG—malignant glioma	6.26e-05	0.000122	CbGpPWpGaD
Pyruvic acid—SLC16A1—Hemostasis—AKT1—malignant glioma	6.11e-05	0.000119	CbGpPWpGaD
Pyruvic acid—AGXT2—Metabolism—AKT1—malignant glioma	6.05e-05	0.000118	CbGpPWpGaD
Pyruvic acid—SLC16A1—Metabolism—PIK3CD—malignant glioma	5.71e-05	0.000111	CbGpPWpGaD
Pyruvic acid—SLC16A3—Metabolism—PIK3CA—malignant glioma	5.61e-05	0.00011	CbGpPWpGaD
Pyruvic acid—PC—Metabolism—AKT1—malignant glioma	5.58e-05	0.000109	CbGpPWpGaD
Pyruvic acid—SLC16A1—Metabolism—PIK3CB—malignant glioma	4.97e-05	9.7e-05	CbGpPWpGaD
Pyruvic acid—SLC16A1—Metabolism—PTGS2—malignant glioma	4.93e-05	9.61e-05	CbGpPWpGaD
Pyruvic acid—SLC16A3—Metabolism—AKT1—malignant glioma	4.59e-05	8.95e-05	CbGpPWpGaD
Pyruvic acid—SLC16A1—Metabolism—PTEN—malignant glioma	4.3e-05	8.39e-05	CbGpPWpGaD
Pyruvic acid—SLC16A1—Metabolism—PIK3CA—malignant glioma	3.03e-05	5.92e-05	CbGpPWpGaD
Pyruvic acid—SLC16A1—Metabolism—AKT1—malignant glioma	2.48e-05	4.83e-05	CbGpPWpGaD
